Observational Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Mar 21, 2021; 27(11): 1064-1075
Published online Mar 21, 2021. doi: 10.3748/wjg.v27.i11.1064
Table 1 Demographic and clinical profile of all candidate patients for liver transplant according to E2, E3 and E4 allele stratification
Variables
APOE2
APOE3
APOE4
P value
Age (yr) (mean ± SD)60.8 ± 7.2660.3 ± 7.1960.3 ± 7.440.956
BMI (mean ± SD)27.6 ± 4.3626.4 ± 5.0127.0 ± 4.810.167
Gender (n1 = 179; n2 = 358), n2 (%)
Male (n1 = 145; n2 = 290)52 (17.9)193 (66.6)45 (15.5)0.650
Female (n1 = 34; n2 = 68)9 (13.2)48 (70.6)11 (16.2)
BMI (n1 = 179; n2 = 358), n2 (%)
Non-obese (n1 = 137; n2 = 274)49 (17.9)185 (67.5)40 (14.6)0.519
Obese (n1 = 42; n2 = 84)12 (14.3)56 (66.7)16 (19.0)
Etiology (n1 = 179; n2 = 358), n2 (%)
HCV (n1 = 74; n2 = 148)24 (16.2)96 (64.9)28 (18.9)0.357
HCV + HCC (n1 = 105; n2= 210)37 (17.6)145 (69.0)28 (13.3)
HCC Milan (n1 = 105; n2= 210), n2 (%)
Within the criteria (n1 = 83; n2 = 166)29 (17.5)115 (69.3)22 (13.2)0.885
Outside the criteria (n1 = 22; n2 = 44)8 (18.2)29 (65.9)7 (15.9)
Table 2 Genotypic and allele distribution of apolipoprotein E according to group, hepatitis C virus serology/viral load and severity of liver inflammation by the METAVIR score of the total population
APOE genotype
Group
HCV-RNA
METAVIR
METAVIR
All
HCV
HCV + HCC
Positive
Negative
≤ A2F4
A3F4
A1F4
A3F4
n1 (179)
n1 (74)
n1 (105)
n1 (33)
n1 (146)
n1 (80)
n1 (11)
n1 (27)
n1 (11)
E2/E2 15 (8.4)6 (8.1)9 (8.6)7 (21.2)8 (5.5)9 (11.2)1 (9.1)4 (14.8)1 (9.1)
E2/E3 25 (14.0)9 (12.2)16 (15.2)3 (9.1)22 (15.1)11 (13.8)2 (18.2)4 (14.8)2 (18.2)
E2/E4 6 (3.3)3 (4.1)3 (2.9)0 (0.0)6 (4.1)2 (2.5)0 (0.0)1 (3.7)0 (0.0)
E3/E3 92 (51.4)36 (48.6)56 (53.3)16 (48.5)76 (52.0)39 (48.8)8 (72.7)12 (44.5)8 (72.7)
E3/E4 32 (17.9)15 (20.3)17 (16.2)5 (15.1)27 (18.5)14 (17.5)0 (0.0)3 (11.1)0 (0.0)
E4/E4 9 (5.0)5 (6.7)4 (3.8)2 (6.1)7 (4.8)5 (6.2)0 (0.0)3 (11.1)0 (0.0)
APOE alleles n2 (%)n2 (%)n2 (%)n2 (%)n2 (%)n2 (%)n2 (%)n2 (%)n2 (%)
E2 61 (17.1)24 (16.2)37 (17.6)17 (25.8)44 (15.1)31 (19.4)4 (18.2)13 (24.1)4 (18.2)
E3 241 (67.3)96 (64.9)145 (69.1)40 (60.6)201 (68.8)103 (64.4)18 (81.8)31 (57.4)18 (81.8)
E4 56 (15.6)28 (18.9)28 (13.3)9 (13.6)47 (16.1)26 (16.2)0(0.0)10 (18.5)0 (0.0)
All 35814821066292160225422
Table 3 METAVIR scores for liver inflammation in pre-orthotopic liver transplantation patients according to E2, E3 and E4 alleles stratification
METAVIR scoreAPOE2

APOE3

APOE4

Yes
No

Yes
No

Yes
No

n2 (%)
n2 (%)
P value
n2 (%)
n2 (%)
P value
n2 (%)
n2 (%)
P value
METAVIR (n1 = 38; n2 = 76)
A1F4 (n1 = 27; n2 = 54)13 (24.1) 41 (75.9)0.76431 (57.4)323 (42.6)0.06410 (18.5)44 (81.5)0.055
A3F4 (n1 = 11; n2 = 22)4 (18.2)18 (81.8)18 (81.8)4 (18.2)0 (0.0)122 (100.0)
METAVIR (n1 = 91; n2 = 182)
≤ A2F4 (n1 = 80; n2 = 160)31 (19.4)129 (80.6)1.000103 (64.4)457 (35.6)0.14826 (16.2)134 (83.8)0.048a
A3F4 (n1 = 11; n2 = 22)4 (18.2)18 (81.8)18 (81.8)4 (18.2)0 (0.0)222 (100.0)
Table 4 Association of the models for end-stage liver disease score and variables in pre-orthotopic liver transplantation patients according to E2, E3 and E4 allele stratification
VariablesMELD≤ 25

MELD> 25

MELD≤ 25

MELD> 25

APOE2
APOE3
APOE4

APOE2
APOE3
APOE4

APOE4

APOE4

(Yes)
(No)

(Yes)
(No)

n2 (%)
n2 (%)
n2 (%)
P value
n2 (%)
n2 (%)
n2 (%)
P value
n2 (%)
n2 (%)
P value
n2 (%)
n2 (%)
P value
METAVIR (n1 = 38; n2 = 76)
A1F4 (n1 = 27; n2 = 54)9 (20.4)27 (61.4)38 (18.2)0.0854 (40.0)4 (40.0)2 (20.0)NA8 (18.2)36 (81.8)0.044a2 (20.0)4 (80.0)NA
A3F4 (n1 = 11; n2 = 22)4 (18.2)18 (81.8)0 (0.0)30 (0.0)0 (0.0)0 (0.0)0 (0.0)22 (100.0)0 (0.0)0 (0.0)
METAVIR (n1 = 91; n2 = 182)
≤ A2F4 (n1 = 80; n2 = 160)26 (18.6)92 (65.7)422 (15.7)0.1235 (25.0)11 (55.0)4 (20.0)NA22 (15.7)118 (84.3)0.046a4 (20.0)16 (80.0)NA
A3F4 (n1 = 11; n2 = 22)4 (18.2)18 (81.8)0 (0.0)40 (0.0)0 (0.0)0 (0.0)0 (0.0)22 (100.0)0 (0.0)0 (0.0)
Table 5 Logistic regression model predicting moderate and severe (A2A3) degree of liver inflammation
Variables
Odds ratio
95%CI
P value
Alcohol consumption0.6360.188-2.1480.466
Gender–male7.6091.195-48.4470.032a
Mean MELD0.9320.829-1.0490.244
Mean age0.9690.893-1.0510.446
Mean BMI 0.8740.782-0.9760.017a
APOE2 1.5190.059-39.3340.801
APOE32.8500.121-66.9170.516
APOE42.8680.112-73.5600.524